Larry Biegelsen
Stock Analyst at Wells Fargo
(3.37)
# 2,363
Out of 4,520 analysts
1301
Total ratings
50%
Success rate
2.1%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Rated: Buy | $109 → $112 | $100.68 | +11.24% | 112 | Jul 17, 2026 | |
| ISRG Intuitive Surgical | Rated: Buy | $654 → $487 | $345.42 | +40.99% | 60 | Jul 17, 2026 | |
| JNJ Johnson & Johnson | Rated: Buy | $263 → $272 | $253.04 | +7.49% | 97 | Jul 16, 2026 | |
| KMTS Kestra Medical Technologies | Rated: Buy | $28 | $24.42 | +14.66% | 6 | Jul 15, 2026 | |
| CNMD CONMED | Maintained: Hold | $42 → $39 | $43.20 | -9.72% | 2 | Jul 11, 2026 | |
| SYK Stryker | Maintained: Buy | $418 | $319.87 | +30.68% | 39 | Jul 8, 2026 | |
| RXST RxSight | Maintained: Hold | $13 → $9 | $5.55 | +62.16% | 25 | Jul 8, 2026 | |
| INSP Inspire Medical Systems | Maintained: Hold | $56 | $50.60 | +10.67% | 38 | Jul 2, 2026 | |
| MDT Medtronic | Maintained: Buy | $102 | $83.20 | +22.60% | 86 | Jun 26, 2026 | |
| AVR Anteris Technologies Global | Maintained: Buy | $16 | $8.45 | +89.35% | 4 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $374 | $318.32 | +17.49% | 47 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $85 | $76.65 | +10.89% | 62 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $255 | $164.06 | +55.43% | 39 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $26 | $16.93 | +53.57% | 3 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $82 → $66 | $71.71 | -7.96% | 44 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $138 | $156.83 | -12.01% | 55 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $90 | $91.12 | -1.23% | 42 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $21 → $27 | $17.08 | +58.08% | 31 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $75 → $55 | $44.03 | +24.91% | 50 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $19 | $16.08 | +18.16% | 12 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $70 | $81.31 | -13.91% | 3 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $35 → $37 | $24.88 | +48.71% | 3 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 → $40 | $27.07 | +47.77% | 2 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $116 → $138 | $134.61 | +2.52% | 20 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $104 → $103 | $77.00 | +33.77% | 12 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $15 | $19.25 | -22.08% | 13 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $14 → $17 | $15.92 | +6.78% | 43 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $78 → $74 | $73.99 | +0.01% | 42 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $48 | $39.85 | +20.45% | 2 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $8.54 | +228.06% | 1 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | CHF 71.07 → CHF 78.34 | CHF 56.70 | +38.17% | 33 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $80 → $84 | $95.42 | -11.97% | 3 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $18 | $16.26 | +10.70% | 57 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $96 → $100 | $85.73 | +16.65% | 65 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $184 → $157 | $158.17 | -0.74% | 40 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 → $97 | $63.07 | +53.80% | 26 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $280 → $270 | $198.99 | +35.69% | 2 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $24 → $19 | $22.61 | -15.97% | 36 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 | $1.40 | +114.29% | 22 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9307 | - | 15 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $20 | $107.59 | n/a | 3 | Aug 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $1.4 | $6.85 | n/a | 3 | Sep 26, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $153.76 | n/a | 1 | Jan 4, 2010 |
Abbott Laboratories
Jul 17, 2026
Rated: Buy
Price Target: $109 → $112
Current: $100.68
Upside: +11.24%
Intuitive Surgical
Jul 17, 2026
Rated: Buy
Price Target: $654 → $487
Current: $345.42
Upside: +40.99%
Johnson & Johnson
Jul 16, 2026
Rated: Buy
Price Target: $263 → $272
Current: $253.04
Upside: +7.49%
Kestra Medical Technologies
Jul 15, 2026
Rated: Buy
Price Target: $28
Current: $24.42
Upside: +14.66%
CONMED
Jul 11, 2026
Maintained: Hold
Price Target: $42 → $39
Current: $43.20
Upside: -9.72%
Stryker
Jul 8, 2026
Maintained: Buy
Price Target: $418
Current: $319.87
Upside: +30.68%
RxSight
Jul 8, 2026
Maintained: Hold
Price Target: $13 → $9
Current: $5.55
Upside: +62.16%
Inspire Medical Systems
Jul 2, 2026
Maintained: Hold
Price Target: $56
Current: $50.60
Upside: +10.67%
Medtronic
Jun 26, 2026
Maintained: Buy
Price Target: $102
Current: $83.20
Upside: +22.60%
Anteris Technologies Global
Jun 15, 2026
Maintained: Buy
Price Target: $16
Current: $8.45
Upside: +89.35%
Jun 12, 2026
Maintained: Hold
Price Target: $374
Current: $318.32
Upside: +17.49%
Jun 10, 2026
Rated: Buy
Price Target: $85
Current: $76.65
Upside: +10.89%
Jun 8, 2026
Maintained: Buy
Price Target: $255
Current: $164.06
Upside: +55.43%
Jun 8, 2026
Maintained: Buy
Price Target: $22 → $26
Current: $16.93
Upside: +53.57%
Jun 5, 2026
Maintained: Hold
Price Target: $82 → $66
Current: $71.71
Upside: -7.96%
Jun 5, 2026
Reiterated: Buy
Price Target: $138
Current: $156.83
Upside: -12.01%
Jun 1, 2026
Rated: Hold
Price Target: $90
Current: $91.12
Upside: -1.23%
Jun 1, 2026
Upgraded: Buy
Price Target: $21 → $27
Current: $17.08
Upside: +58.08%
May 28, 2026
Downgraded: Hold
Price Target: $75 → $55
Current: $44.03
Upside: +24.91%
May 27, 2026
Rated: Buy
Price Target: $19
Current: $16.08
Upside: +18.16%
May 22, 2026
Maintained: Hold
Price Target: $70
Current: $81.31
Upside: -13.91%
May 15, 2026
Rated: Buy
Price Target: $35 → $37
Current: $24.88
Upside: +48.71%
May 8, 2026
Maintained: Buy
Price Target: $42 → $40
Current: $27.07
Upside: +47.77%
May 8, 2026
Maintained: Hold
Price Target: $116 → $138
Current: $134.61
Upside: +2.52%
May 8, 2026
Maintained: Buy
Price Target: $104 → $103
Current: $77.00
Upside: +33.77%
May 6, 2026
Maintained: Hold
Price Target: $12 → $15
Current: $19.25
Upside: -22.08%
May 4, 2026
Rated: Hold
Price Target: $14 → $17
Current: $15.92
Upside: +6.78%
May 1, 2026
Maintained: Hold
Price Target: $78 → $74
Current: $73.99
Upside: +0.01%
Apr 29, 2026
Maintained: Buy
Price Target: $40 → $48
Current: $39.85
Upside: +20.45%
Mar 17, 2026
Maintained: Buy
Price Target: $28
Current: $8.54
Upside: +228.06%
Feb 26, 2026
Upgraded: Buy
Price Target: CHF 71.07 → CHF 78.34
Current: CHF 56.70
Upside: +38.17%
Feb 20, 2026
Maintained: Hold
Price Target: $80 → $84
Current: $95.42
Upside: -11.97%
Feb 19, 2026
Maintained: Hold
Price Target: $17 → $18
Current: $16.26
Upside: +10.70%
Feb 11, 2026
Reiterated: Buy
Price Target: $96 → $100
Current: $85.73
Upside: +16.65%
Feb 10, 2026
Maintained: Hold
Price Target: $184 → $157
Current: $158.17
Upside: -0.74%
Feb 5, 2026
Maintained: Buy
Price Target: $95 → $97
Current: $63.07
Upside: +53.80%
Jan 30, 2026
Maintained: Hold
Price Target: $280 → $270
Current: $198.99
Upside: +35.69%
Dec 12, 2025
Maintained: Hold
Price Target: $24 → $19
Current: $22.61
Upside: -15.97%
Nov 13, 2025
Maintained: Hold
Price Target: $3
Current: $1.40
Upside: +114.29%
Oct 21, 2025
Rated: Hold
Price Target: n/a
Current: $0.9307
Upside: -
Aug 2, 2018
Reiterated: Buy
Price Target: $26 → $20
Current: $107.59
Upside: n/a
Sep 26, 2013
Downgraded: Hold
Price Target: $15 → $1.4
Current: $6.85
Upside: n/a
Jan 4, 2010
Upgraded: Buy
Price Target: n/a
Current: $153.76
Upside: n/a